德视佳2026年上半年营收4.54亿港元,经调整净利润3,801万元

公告速递
Aug 31

本季度信息

德视佳披露的最新财报显示,截至2026年6月30日止六个月,公司实现营收4.54亿港元,同比增长20.5%;经调整净利润3,801万元,同比微降约1%。报告期内,毛利率为39.4%,较上年同期下降2.2个百分点;公司经营利润(EBITDA)约7,914万元,同比下降40.0%,经营利润率17.4%。经营活动所得现金流为9,102万元,同比下降约10.4%。成本方面,报告期内公司销售费用与管理费用增幅较快,销售费用率(剔除新增收购影响)约为11.9%,上年同期为11.1%。公司将继续加大在老花眼矫正领域的投入,并在多市场推动业务协同。

业务分项

公司在德国市场营收2.33亿港元,同比增长15.8%,在老花眼矫正需求持续增长的带动下创下历史新高。中国(含香港)市场在强化营销举措后实现营收0.83亿港元,较上年同期增长12.6%。英国业务营收0.67亿港元,同比增长7.6%,主要来自老花眼和近视矫正手术量稳步提高。丹麦市场受局部竞争加剧影响,营收0.34亿港元,下降16.9%。瑞士业务处于整合期,本期贡献营收0.38亿港元。管理层表示将继续通过提升诊所使用率及整合近期收购的业务,进一步扩大规模并增强盈利能力。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10